Current Best Practice in Rehabilitation in Interstitial Lung Disease

Overview

Journal Ther Adv Respir Dis

Publisher Sage Publications

Specialties Pharmacology
Pulmonary Medicine

Date 2017 Feb 3

PMID 28150539

Citations 27

Authors

Atsuhito Nakazawa

Narelle S Cox

Anne E Holland

Affiliations

Soon will be listed here.

Abstract

Interstitial lung disease (ILD) is a group of chronic respiratory diseases characterized by dyspnoea on exertion and decline in health-related quality of life (HRQL). People with ILD experience significant exercise limitation with contributors that include ventilatory limitation, impaired gas exchange, decreased cardiac function and skeletal muscle dysfunction. Pulmonary rehabilitation (PR) is well established in patients with chronic obstructive pulmonary disease (COPD) as a means to overcome exercise limitation and improve activity-related dyspnoea. There is increasing evidence for similar effects of PR in people with ILD. This review discusses the evidence for PR in ILD, outlines the essential components of PR in this population, and highlights special considerations for exercise training in people with ILD. Possible future directions for PR research in people with ILD are explored.

Citing Articles

The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases.

Luppi F, Manfredi A, Faverio P, Brun Andersen M, Bono F, Pagni F BMC Pulm Med. 2023; 23(1):501.

PMID: 38082233 PMC: 10714466. DOI: 10.1186/s12890-023-02783-z.

The interplay of physical and cognitive function in rehabilitation of interstitial lung disease patients: a narrative review.

Hanada M, Tanaka T, Kozu R, Ishimatsu Y, Sakamoto N, Orchanian-Cheff A J Thorac Dis. 2023; 15(8):4503-4521.

PMID: 37691666 PMC: 10482628. DOI: 10.21037/jtd-23-209.

Therapeutic Approaches for the Treatment of Interstitial Lung Disease: An Exploratory Review on Molecular Mechanisms.

Amin R, Pandey R, Vaishali K, Acharya V, Sinha M, Kumar N Mini Rev Med Chem. 2023; 24(6):618-633.

PMID: 37587813 DOI: 10.2174/1389557523666230816090112.

Effects of walking with a portable oxygen concentrator on muscle oxygenation while performing normal or pursed-lip breathing in patients with interstitial lung disease: a randomized crossover trial.

Kim S, Shin Y, Shin M, Hong C, Huh S, Yoo W Ther Adv Respir Dis. 2023; 17:17534666231186732.

PMID: 37462163 PMC: 10357056. DOI: 10.1177/17534666231186732.

Exercise-Based Pulmonary Rehabilitation for Interstitial Lung Diseases: A Review of Components, Prescription, Efficacy, and Safety.

Mendes R, Castello-Simoes V, Trimer R, Garcia-Araujo A, da Silva A, Dixit S Front Rehabil Sci. 2022; 2:744102.

PMID: 36188788 PMC: 9397914. DOI: 10.3389/fresc.2021.744102.

References

Beauchamp M, Nonoyama M, Goldstein R, Hill K, Dolmage T, Mathur S . Interval versus continuous training in individuals with chronic obstructive pulmonary disease--a systematic review. Thorax. 2009; 65(2):157-64. DOI: 10.1136/thx.2009.123000. View

Kim J, Lee J, Ryu Y, Chang J . Clinical predictors of survival in idiopathic pulmonary fibrosis. Tuberc Respir Dis (Seoul). 2012; 73(3):162-8. PMC: 3492401. DOI: 10.4046/trd.2012.73.3.162. View

Araujo M, Baldi B, Freitas C, Albuquerque A, Marques da Silva C, Kairalla R . Pulmonary rehabilitation in lymphangioleiomyomatosis: a controlled clinical trial. Eur Respir J. 2016; 47(5):1452-60. DOI: 10.1183/13993003.01683-2015. View

Vainshelboim B, Oliveira J, Fox B, Soreck Y, Fruchter O, Kramer M . Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis. Lung. 2015; 193(3):345-54. DOI: 10.1007/s00408-015-9703-0. View

du Bois R, Albera C, Bradford W, Costabel U, Leff J, Noble P . 6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2013; 43(5):1421-9. DOI: 10.1183/09031936.00131813. View

Bajwah S, Ross J, Wells A, Mohammed K, Oyebode C, Birring S . Palliative care for patients with advanced fibrotic lung disease: a randomised controlled phase II and feasibility trial of a community case conference intervention. Thorax. 2015; 70(9):830-9. DOI: 10.1136/thoraxjnl-2014-206583. View

Holland A, Spruit M, Troosters T, Puhan M, Pepin V, Saey D . An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014; 44(6):1428-46. DOI: 10.1183/09031936.00150314. View

Holland A, Dowman L, Hill C . Principles of rehabilitation and reactivation: interstitial lung disease, sarcoidosis and rheumatoid disease with respiratory involvement. Respiration. 2015; 89(2):89-99. DOI: 10.1159/000370126. View

Spitzer R, Kroenke K, Williams J, Lowe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-7. DOI: 10.1001/archinte.166.10.1092. View

10.

Vainshelboim B, Oliveira J, Yehoshua L, Weiss I, Fox B, Fruchter O . Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis. Respiration. 2014; 88(5):378-88. DOI: 10.1159/000367899. View

11.

Strookappe B, Swigris J, de Vries J, Elfferich M, Knevel T, Drent M . Benefits of Physical Training in Sarcoidosis. Lung. 2015; 193(5):701-8. DOI: 10.1007/s00408-015-9784-9. View

12.

Agusti A, Roca J, Gea J, Wagner P, Xaubet A, Rodriguez-Roisin R . Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1991; 143(2):219-25. DOI: 10.1164/ajrccm/143.2.219. View

13.

Eaton T, Young P, Milne D, Wells A . Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med. 2005; 171(10):1150-7. DOI: 10.1164/rccm.200405-578OC. View

14.

Mahler D, Wells C . Evaluation of clinical methods for rating dyspnea. Chest. 1988; 93(3):580-6. DOI: 10.1378/chest.93.3.580. View

15.

Patel A, Siegert R, Brignall K, Gordon P, Steer S, Desai S . The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Thorax. 2012; 67(9):804-10. DOI: 10.1136/thoraxjnl-2012-201581. View

16.

Morisset J, Dube B, Garvey C, Bourbeau J, Collard H, Swigris J . The Unmet Educational Needs of Patients with Interstitial Lung Disease. Setting the Stage for Tailored Pulmonary Rehabilitation. Ann Am Thorac Soc. 2016; 13(7):1026-33. PMC: 6138059. DOI: 10.1513/AnnalsATS.201512-836OC. View

17.

Mendes P, Wickerson L, Helm D, Janaudis-Ferreira T, Brooks D, Singer L . Skeletal muscle atrophy in advanced interstitial lung disease. Respirology. 2015; 20(6):953-9. DOI: 10.1111/resp.12571. View

18.

Singh S, Morgan M, Scott S, Walters D, Hardman A . Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992; 47(12):1019-24. PMC: 1021093. DOI: 10.1136/thx.47.12.1019. View

19.

Alakhras M, Decker P, Nadrous H, Collazo-Clavell M, Ryu J . Body mass index and mortality in patients with idiopathic pulmonary fibrosis. Chest. 2007; 131(5):1448-53. DOI: 10.1378/chest.06-2784. View

20.

Pison C, Cano N, Cherion C, Caron F, Court-Fortune I, Antonini M . Multimodal nutritional rehabilitation improves clinical outcomes of malnourished patients with chronic respiratory failure: a randomised controlled trial. Thorax. 2011; 66(11):953-60. DOI: 10.1136/thx.2010.154922. View